Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for December 2007
December 3, 2007
- FDA Advisors Declare 'FDA Science and Mission at Risk'
- Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and Stock
- Evotec Completes Divesture of Chemical Development Business to Aptuit
- Santarus Licenses Rights to GlaxoSmithKline for Zegerid Immediate-Release Omeprazole Products in over 100 Countries
- StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy, LLC
- Addex and Merck & Co., Inc. Collaborate to Develop Drugs for Parkinson's Disease
- Do Medical Schools Affect the Way Future Doctors Interact with Drug Companies?
- Sanofi-Aventis Inaugurates First Asian Development Centre for Pharmaceuticals in Goa, India
- Novartis Further Strengthens Biologics Capabilities in Expansion of MorphoSys Collaboration
- MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therapeutic Antibody Pipeline
- King Pharmaceuticals Reports Petition for Rehearing and Rehearing En Banc Denied
December 4, 2007
- Merck Anticipates Earnings per Share Growth in 2008; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding Certain Items
- Watson and Biovail Settle Lawsuit Over Cardizem LA
- Decision Resources Inc. to Acquire Wood Mackenzie's Life Sciences Business
- Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed
- HBIO Divests the Majority of its Capital Equipment Business
- Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
- AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project
- Rep. Waxman Urges Strong Response to Report on FDA Resource Shortfalls
- Anika Therapeutics and Galderma Complete Termination of License, Development and Supply Agreements
- Compendia Bioscience Signs Oncomine Licensing Agreement with AstraZeneca
- Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
- Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer's Disease
- FDA MedWatch - Desmopressin Acetate - Product Labeling Updated To Include Important New Information About Severe Hyponatremia And Seizures
- Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
- Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and Stock
December 5, 2007
- Amarin Signs Agreement to Acquire Ester Neurosciences
- Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds
- Synta Receives $80 Million Upfront Payment from GlaxoSmithKline
- Revolution Health Acquires HealthTalk
- Akorn, Inc. Announces First ANDA Submission For Serum Institute of India, Ltd.
- Chemokine Therapeutics Withdraws Registration Statement and Implements a Cost Reduction Plan
- Bristol-Myers Squibb Announces Closing Of Its Colón, Panama Manufacturing Facility
- R&D Tax Credit Essential for a Healthier America
- Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
- Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule
December 6, 2007
- Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
- IMPAX Submits Additional Information to FDA Related to ANDA For Generic Version of Opana ER
- BioCryst Provides Forodesine HCl Update
- Michigan Health Plans Continue Focus on Generics for Cost Savings
- Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
- Sun Pharma Announces Settlement of Litigation Over Generic Exelon
- Video and Photo: EMD Serono Launches easypod, New Electronic Growth Hormone Injection Device
- Sepragen Announces the Completion of Cyto Biologic Technologies Acquisition
- ATEL Ventures Portfolio Company, ARYx Therapeutics, Inc. Completes Initial Public Offering
- Safety Concerns Prompt Prime to Remove Avandia from Formulary
- Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics
- QPS Announces Signing Agreement to Acquire Bio-Kinetic Clinical Applications, Gaining Phase I and Early Clinical Services
- NCPA Testifies Before House Small Business Committee
December 7, 2007
- Watson and Novartis Settle Lawsuit Over Exelon Patent Litigation
- Watson and Novartis Settle Lawsuit Over Exelon Patent Litigation
- Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
- Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
- AstraZeneca Presents its Global Biologics Organization, MedImmune, at 2007 Analyst and Investor R&D Day
- Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives
- Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
- ImClone and Sanofi-Aventis Settle Patent Litigation with Yeda Research and Development Corporation
December 10, 2007
- GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
- Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser
- Meda: Competition Authority Approves Meda's Acquisition of Recip
- Eisai to Acquire MGI Pharmafor $41 Per Share in an All Cash Transaction
- Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
- New Data Show Glivec Halts Progression to Advanced Stages of Life-threatening Form of Leukemia in Sixth Year of Treatment
- Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
- Acura Pharmaceuticals, Inc. Announces Receipt of $30 Million Cash Payment and Closing of Agreement With King Pharmaceuticals
- Pivotal Phase III Data Showed Rivaroxaban Was Statistically Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE) in Patients Following Hip Replacement Surgery
- ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.
- New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
- FDA's Safety Reviews of Prilosec and Nexium Find No Evidence of Increased Rates of Cardiac Events
- Commonwealth Biotechnologies Completes Integration Program for its Complementary Drug Discovery Businesses
December 11, 2007
- Novo Nordisk Settles With Pfizer On Patent Infringement Suit
- Novo Nordisk Settles With Pfizer On Patent Infringement Suit
- Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
- Replidyne Provides Strategic Update
- Trimeris Announces 2008 Strategic Plan
- Biovail Announces Proposed Settlement of U.S. Securities Class Action
- Merck Reviews Progress on Strategic Plan at 2007 Annual Business Briefing
- First New Opioid Dependence Treatment in More Than 30 years
December 12, 2007
- AstraZeneca Files Patent Infringement Actions in Response to Crestor ANDAs
- AstraZeneca Files Patent Infringement Actions in Response to Crestor ANDAs
- West Pharmaceutical Services Announces Restructuring Plan for Tech Group
- Survey Finds At-Risk Consumers Interested in OTC Statin
- Use of Diabetes Medication by Older Adults Associated with Increased Risk of Serious Heart Problems, Death
- Influenza Pandemic Could Cost Canadian Economy $9 Billion
- Three Lots of Measles, Mumps and Rubella Vaccine Suspended from Use
- Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania
- Medicis and Revance Announce Strategic Collaboration
- FDA Issues an FDA Alert and Information for Healthcare Professionals Sheet for Carbamazepine
- MPM BioEquities Demands VaxGen Drop Merger Plan with Raven
- Celsion Purchases 659,738 Shares of Celsion Common Stock from Boston Scientific
December 13, 2007
- Biogen Idec Completes Review of Strategic Alternatives
- Court Grants Depomed's Motion for Summary Judgment of Patent Infringement Against IVAX
- Shire plc: Board Changes
- Merck Announces Voluntary Recall of Certain Lots of Pedvaxhib and Comvax
- Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
- Elan Update
- European Pharmaceutical Industry is Key to Helping Eu Become the Most Competitive and Dynamic Knowledge-based Society in the World
- Odyssey Thera Receives Milestone Payments in Pfizer Collaboration
- Cholesterol-Lowering Drugs and the Risk of Hemorrhagic Stroke
- Novartis Launches Strategic Initiative to Improve Competitiveness in a Dynamically Changing Healthcare Environment
- The Labeling for Exjade (deferasirox) has Been Changed to Include Information about Postmarketing Reports of Hepatic Failure, Some with a Fatal Outcome
December 14, 2007
- Neurocrine Announces Work Force Restructuring
- FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription Mevacor (lovastatin) 20 mg
- GlaxoSmithKline, Via Its Center of Excellence for External Drug Discovery, Exercises Its Option to Further Develop and Commercialize Exelixis' Anti-Cancer C-MET Inhibitor XL880
- European Medicines Agency Concludes New Advice to Doctors and Patients for Champix Needed
- European Medicines Agency Recommends Withdrawal of the Marketing Authorisations for Lumiracoxib-Containing Medicines
- Committee for Medicinal Products for Human Use Post-authorisation Summary of Positive Opinion for Humira
- Merck Settles Clean Water Act Violations at its Montgomery County, Pennsylvania Pharmaceutical Plant
- I-Flow Announces Agreement to Acquire AcryMed, Inc.
- Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
- FDA Sends Wyeth Warning Letter Over Effexor Ad
December 17, 2007
- Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
- Highly Promising Dutch Research Into Alzheimer's Disease and Parkinson's Disease
- Gene Logic Inc. Completes Sale of Genomics Assets to Ocimum Biosolutions
- HBIO Board Unanimously Rejects Skystone's Offer to Acquire the Company.
- Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
- OncoVista Increases Its Share in AdnaGen AG
- Ambrx Announces Drug Discovery Alliance With Eli Lilly and Company
- Oncothyreon to Receive $5 Million Payment
- Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million
- FDA Announces Updated Information Regarding Antiretroviral Agents Used as HIV Postexposure Prophylaxis for Occupational HIV Exposures
- Aspreva Obtains Shareholder Approval for Acquisition by Galenica
December 18, 2007
- Lilly and BioMS Medical Announce Global Licensing and Development Agreement
- Galapagos Announces Milestone Payment of €7.5 Million in Osteoarthritis Alliance with Glaxosmithkline
- Astellas Pharma Inc. and Toray Industries, Inc. Launch PAH Agent in Japan
- Eisai Enters Into In-licensing Agreement with Minophagen Pharmaceutical for Liver Disease/Allergic Disease AgentsStronger Neo-Minophagen C and Glycyron Tablets
- Lu AA21004 For the Treatment of Mood and Anxiety Disorders Enters Into Clinical Phase III
- Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor
- PM Announces Canada’s New Food and Consumer Safety Action Plan
- Pfizer to Acquire CovX to Extend Biotherapeutics Investment
- BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
- ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates
December 19, 2007
- FDA Grants Tentative Approval to First Generic for Antiretroviral Viread
- Idera Pharmaceuticals and Merck KGaA to Collaborate on Development of TLR9 Agonists for Treatment of Cancer
- Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
- Decision Resources, Inc. Acquires Arlington Medical Resources, Inc.
- GlaxoSmithKline Completes Acquisition of Reliant Pharmaceuticals
- Alkermes Announces Receipt of $166 Million from Sale of Stake in Reliant Pharmaceuticals
- Antisense Pharma With New Management Structure
- Galapagos Announces Osteoporosis Collaboration with Lilly
- Biogen Idec Announces First Startup in Its Innovation Incubator
- AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease
- DSM Dyneema to Become Separately Reporting Business Group
- Enzo Biochem Unit Signs Letter of Intent to Acquire Belgian Life Sciences Distributor
December 20, 2007
- Akela Pharma Provides Corporate Update
- Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
- Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins
- Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
- Compugen and Roche Sign Agreement to Identify Genetic Variations Predictive of Drug Response in Rheumatoid Arthritis Patients
- Hemispherx Biopharma Comments on 2005 BDO Audit News
- Valeant Pharmaceuticals Sells Hep-C Drug Infergen to Three Rivers Pharmaceuticals, LLC for $91 Million
- Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights
- Marketing of Viadur (leuprolide acetate implant) to Phase Out by April 2008
- Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
- NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
- Scripps Research Discovery Leads to Broad Potential Applications in CovX-Pfizer Deal
- Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration
- Agilent Technologies Completes Acquisition of Velocity11, a Leader in Life Science Lab Automation and Robotics
December 21, 2007
- Avastin Press Statement
- Daiichi Sankyo to Dissolve Subsidiary
- Daiichi Sankyo Announces Merger of Subsidiaries
- Lundbeck Expands Agreement with Paion for Desmoteplase
- FDA MedWatch - Fentanyl Transdermal System - Updated Information On Appropriate Prescribing, Dose Selection, and Safe Use
- Public Communication - Health Canada Endorsed Important Safety Information on Alertec (modafinil)
- Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i
December 26, 2007
- Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of Protonix Patent
- Transition Therapeutics Announces Milestone Payment from Elan
- Cubist Pharmaceuticals Acquires Illumigen Biosciences
- Eisai Introduces New Aricept Dose Formulations for Treatment of Severe Alzheimer's Disease in Japan
- IMS Health, Wolters Kluwer Health and Verispan Comment on Federal Judge's Decision to Grant Preliminary Injunction Blocking Enforcement of Maine Prescription Restraint Law
- Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
December 27, 2007
- U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT ANDA Filing
- MultiCell Technologies To Increase Focus on Therapeutic Candidates
- Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024
- Astellas Won the Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon Capsule
- Three Steps to Boost Asymchem's Investment in China
- MedCap Opposes VaxGen's Proposed Merger with Raven biotechnologies
- The Medical House PLC Announces Disposal of Loss-Making Sub-contract Machining Division
- Cell Therapeutics, Inc. Completes Acquisition of Lymphoma Drug Zevalin From Biogen Idec for Sales and Marketing in the United States
- Exelgen Announces Partnerships with Two Leading European Biotechnology Companies
- Columbia River Resources Inc. Acquires Cutting-Edge Pharmaceutical RFID Company
